Astera Labs (NASDAQ:ALAB) Trading Up 2.1% – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB) shares were up 2.1% on Wednesday . The stock traded as high as $326.97 and last traded at $325.33. Approximately 5,117,810 shares were traded during mid-day trading, a decline of 8% from the average daily volume of 5,543,899 shares. The stock had previously closed at $318.72.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ALAB. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target for the company. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday. Finally, Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Trading Down 1.8%

The firm has a market cap of $58.80 billion, a P/E ratio of 231.34, a price-to-earnings-growth ratio of 4.31 and a beta of 3.35. The firm’s 50 day moving average is $186.48 and its two-hundred day moving average is $163.86.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,316,257 shares of company stock worth $474,860,636 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the business. Atreides Management LP raised its holdings in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the period. Amundi boosted its holdings in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Rafferty Asset Management LLC bought a new stake in shares of Astera Labs during the third quarter worth $209,599,000. Finally, BNP Paribas Financial Markets increased its position in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.